DelveInsight has launched a new report on “Alcoholic Hepatitis – Market Insights, Epidemiology, and Market Forecast-2032”.
DelveInsight’s “Alcoholic Hepatitis – Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Alcoholic Hepatitis, historical and forecasted epidemiology as well as the Alcoholic Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Alcoholic Hepatitis Market Report:
- A literature review has also suggested that although Alcoholic Hepatitis is an acute condition, nearly 50% of patients with AH have established cirrhosis at the time of clinical presentation.
- Although patients drinking ≥ 30-50 g/d for more than 5-10 years are considered at risk for developing Alcoholic Liver Disease (ALD), the disease does not develop in everyone with this amount of alcohol consumption. About 90% to 100% of heavy drinkers have steatosis, 10% to 35% have AH, and 8% to 20% have alcoholic cirrhosis.
Key benefits of the report:
- Alcoholic Hepatitis market report covers a descriptive overview and comprehensive insight of the Alcoholic Hepatitis epidemiology and Alcoholic Hepatitis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Alcoholic Hepatitis market report provides insights on the current and emerging therapies.
- Alcoholic Hepatitis market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Alcoholic Hepatitis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Alcoholic Hepatitis market.
Got queries? Click here to know more about the Alcoholic Hepatitis Market Landscape.
Alcoholic Hepatitis Overview
Alcoholic hepatitis is inflammation of the liver caused by drinking alcohol. Alcoholic hepatitis is most likely to occur in people who drink heavily over many years. However, the relationship between drinking and alcoholic hepatitis is complex. Not all heavy drinkers develop alcoholic hepatitis, and the disease can occur in people who drink only moderately.
The key players involved in the Alcoholic Hepatitis market:
- Afimmune
- Durect
- And others
The launch of the emerging therapies is expected to significantly impact the Alcoholic Hepatitis treatment scenario in the upcoming years:-
Drug covered
- DS102
- DUR-928
- And others.
Table of Contents:
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Alcoholic Hepatitis Patient Share (%) Overview at a Glance
5. Alcoholic Hepatitis Market Overview at a Glance
6. Alcoholic Hepatitis Disease Background and Overview
7. Alcoholic Hepatitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Alcoholic Hepatitis
9. Alcoholic Hepatitis Current Treatment and Medical Practices
10. Unmet Needs
11. Alcoholic Hepatitis Emerging Therapies
12. Alcoholic Hepatitis Market Outlook
13. Country-Wise Alcoholic Hepatitis Market Analysis (2019–2032)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Alcoholic Hepatitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To request a sample report, click here Alcoholic Hepatitis Market Outlook 2032.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/